Delivery Order SPE2DB20D7059-SPE2DB26FGRR5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,557.56 to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 30-gram quantities. This non-competitive, firm fixed-price delivery order was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,534.08 by the Defense Logistics Agency on August 19, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram quantities. The contract utilizes firm fixed pricing and carries an ultimate completion date of August 20, 2025. This competitively awarded delivery order, which includes no set-aside designation, is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 100-gram quantities, with a ceiling value of $2,181.45. The contract was competitively awarded without set-aside designation and is structured as a firm fixed-price delivery order with an ultimate completion date of August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in a 30-gram quantity, valued at $20,510.86. This delivery order, issued on September 11, 2025, represents a firm fixed-price contract with an ultimate completion date of September 12, 2025. The contract carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a $1,207.19 delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in 30-gram units under a firm fixed-price contract with an ultimate completion date of September 23, 2025. This is a non-set-aside, competitively awarded delivery order executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in a 30-gram unit, with a contract value of $1,125.26. This is a firm fixed-price delivery order with no set-aside designation, awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,480.02 to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram quantities. This is a firm fixed-price delivery order with an ultimate completion date of October 20, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award is a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitive delivery order award from the Defense Logistics Agency (DLA) for Pimecrolimus 1% Cream in a 30-gram size with a ceiling value of $1,404.72. The contract is structured as a firm fixed price delivery order with an ultimate completion date of October 16, 2025, and was awarded on October 15, 2025. No set-aside designation was applied to this award, indicating it was...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 2, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram units, with a ceiling value of $1,484.50. This firm fixed-price delivery order, with an ultimate completion date of July 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation....
- The Defense Logistics Agency awarded a delivery order valued at $2,031.34 to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in 100-gram quantities. This non-competitive delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed-price procurement executed under a child contract mechanism. The contractor, headquartered in Conshohocken, Pennsylvania, performed this order from its corporate office location. Pimecrolimus is a...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB26FGRR5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,398.76 to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 30-gram quantities. This non-competitive, firm fixed-price delivery order was awarded on November 3, 2025, with an ultimate completion date of November 4, 2025. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor serving military and veteran medical systems through the Defense Logistics Agency's Medical Supply Chain. As a competitively awarded prime contractor, the company maintains an extensive portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The company's federal procurement track record demonstrates its capability to fulfill diverse medical supply needs ranging from small-value transactions to substantial orders, consistently delivered under firm fixed-price arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 11/3/25 |